Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Options Exercise | $1.52M | +45.5K | +15.05% | $33.48 | 348K | Nov 1, 2021 | Direct | F1 |
transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Sale | -$2.57M | -45.5K | -13.08% | $56.47 | 302K | Nov 1, 2021 | Direct | F1, F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ST | Stock options to Buy | Options Exercise | $0 | -45.5K | -100% | $0.00* | 0 | Nov 1, 2021 | Ordinary Shares, par value EUR 0.01 per share | 45.5K | $33.48 | Direct | F4 |
Id | Content |
---|---|
F1 | Includes 17,250 unvested restricted securities subject to the reporting person's continued service. |
F2 | Reflects the sale of an aggregate of 45,530 shares of common stock on November 1, 2021, at the weighted average sales price of $56.4682. The prices for these sales range from $56.40 to $56.76. |
F3 | The filer undertakes to provide, upon request by the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F4 | This option grant became exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2013. |